We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
22 hedge funds and large institutions have $1.33M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
16% more funds holding
Funds holding: 19 → 22 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
26% less capital invested
Capital invested by funds: $1.8M → $1.33M (-$463K)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
22
Holders Change
+3
Holders Change %
+15.79%
% of All Funds
0.29%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
3
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$29.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$894 |
| 3 |
BlackRock
New York
|
+$209 |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$21 |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$10 |
